The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.
 
Jean M. Hansen
No Relationships to Disclose
 
Kari Lassen Ring
No Relationships to Disclose
 
Keith A. Baggerly
No Relationships to Disclose
 
Sherry Wu
No Relationships to Disclose
 
Kirsten Timms
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Research Funding - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Myriad Genetics
 
Christopher Neff
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Research Funding - Myriad Genetics
 
Elisha Hughes
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Research Funding - Myriad Genetics
 
Rebecca A. Previs
No Relationships to Disclose
 
Russell Broaddus
No Relationships to Disclose
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; DOD-CDRMP; Esperance Pharmaceuticals; Genentech/Roche; NCCN
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bayer; Clovis Oncology; Gradalis; Merck; Merrimack; Millennium
 
Karen H. Lu
No Relationships to Disclose
 
Anil Sood
No Relationships to Disclose